Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?
Alessio Mosca, Filippo Maria Ferro
2026, 2(1): 5. doi: 10.53941/cna.2026.100005
Brexpiprazole in the Management of Schizophrenia and Comorbid Substance Use Disorders: A Narrative Review of Efficacy, Safety, and Real-World Evidence (2020–2026)
Miriam Olivola, Nicolaja Girone, Andrea Crippa, Monica Macellaro, Vassilis Martiadis, Fabiola Raffone, Tiziano Prodi, Natascia Brondino, Roberta Anniverno, Bernardo Dell’Osso
2026, 2(1): 3. doi: 10.53941/cna.2026.100003

Valerio Ricci
2025, 1(1): 4. doi: 10.53941/cna.2025.100004